# Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia

> **NCT02677064** · — · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 1365 (estimated)

## Conditions studied

- Acute Leukemia
- Newly Diagnosed
- Relapsed

## Interventions

- **OTHER:** assessments

## Key facts

- **NCT ID:** NCT02677064
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2016-02
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 1365 (ESTIMATED)
- **Last updated:** 2026-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02677064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02677064, "Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02677064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*